Daily Supplement Proven to Help With Osteoarthritis

Five words or less(NewsUSA) – New research using cutting-edge Magnetic Resonance Imaging (MRI) for the first time confirms that pharmaceutical grade chondroitin sulphate (CSbBIO-ACTIVE) significantly helps reduce the effects of osteoarthritis in the knee.
Osteoarthritis is the most common form of arthritis, affecting 27 million people in the U.S. alone. Over time, this condition leads to breakdown of the cartilage and other parts of the joint, causing stiffness, pain and loss of movement. Cartilage is a firm, rubbery covering on the ends of joint bones that reduces friction and acts as a shock absorber. With osteoarthritis, the cartilage loses elasticity and wears away; without the cushioning cartilage provides, the bones can rub against each other. Cartilage deterioration can affect the shape and makeup of the joint so it no longer functions smoothly. Also, bruises called bone marrow lesions can develop inside the bone and may cause knee pain.
Trial results recently published in a leading arthritis journal showed that chondroitin sulphate treatment significantly reduced cartilage loss and bone marrow lesions from osteoarthritis of the knee.
Chondroitin is a natural substance in the body that helps keep cartilage healthy by absorbing fluid and providing building blocks to produce new cartilage. Chondroitin may also block enzymes that break down cartilage.
Recent advances in MRI made it possible for Dr. Jean-Pierre Pelletier and his team at University of Montreal Hospital Research Centre in Canada to measure for the first time the impact of chondroitin sulfate on cartilage loss and other changes to the joint, including bone marrow lesions. The latest technology enabled researchers to measure and demonstrate significant improvements after treatment with chondroitin sulphate.
By six months, patients showed significantly less cartilage loss compared with those receiving placebo. By 12 months, treatment significantly decreased bone marrow lesion size.
“Reducing bone marrow lesions may help lessen some of the pain associated with osteoarthritis,” said Dr. Pelletier. “From these results, we can conclude that chondroitin sulfate is a safe drug that significantly reduces the volume of cartilage loss and slows down the progression of osteoarthritis in the knee.” He notes, “Patients must be provided highly purified pharmaceutical-grade chondroitin sulphate, the one used in this study, as this is the only one that can guarantee such efficacy and specifically, safety results.”

Baby Boomers: Don’t Let Osteoarthritis Slow You Down

div img class=”category-img” src=”http://ftper.newsusa.com/Thumbnail/BoomersDontSlowDown.jpg” alt=”Five words or less” width=”180″ //divdiv class=”category-listcontent”div class=”category-body” id=”ArticleBody” style=”display: block” (a href=”http://www.newsusa.com”NewsUSA/a) – Osteoarthritis affects an estimated 27 million Americans and is the most common type of arthritis. Women over the age of 50 have a greater risk of …/div/div

Baby Boomers: Don’t Let Osteoarthritis Slow You Down

Five words   or less(NewsUSA) – Osteoarthritis affects an estimated 27 million Americans and is the most common type of arthritis. Women over the age of 50 have a greater risk of …

Treat Pain Without Popping Pills

<b>Treat Pain Without Popping Pills</b>“></td>
<p>(<a href=NewsUSA) – When Americans feel a pain coming on -; whether from a headache, backache or sore muscle -; they reach for their medicine cabinets. And while popping a pain pill on occasion probably won’t cause lasting harm, overuse of even over-the-counter drugs can prove harmful.

Most people think nothing of taking painkillers like Advil, Aleve, Ibuprofen, Motrin and aspirin. But these common pills belong to a class of drugs called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which are known to cause gastric ulcers, cardiovascular problems, gastrointestinal bleeding, and liver and kidney damage.

Acetaminophen, or Tylenol, can damage the liver, especially in those who drink alcohol on a regular basis. In fact, according to the Food and Drug Administration, Osteoarthritis” liver toxicity from acetaminophen poisoning is the most common cause of acute liver failure in the United States.

Taking more than the recommended dosage increases the risk of side effects, as does taking the drugs over a long period of time, Those managing chronic pain with NSAIDs or acetaminophen prove especially susceptible to damage.

Osteoarthritis patients often use over-the-counter or prescription painkillers to relieve pain and inflammation. But in doing so, they risk developing new health problems, some of which may prove life-threatening.

But there are other ways to treat pain. For example, the FDA has recently approved an at-home low-level laser device, the QLaser, for treating osteoarthritis in the hands. Low-level lasers have also been approved for treating carpal tunnel syndrome and myofascial shoulder pain.

Low-level laser therapy uses laser light to ease pain by stimulating endorphins, reduce inflammation and encourage cell regeneration. Long used by professional athletes and the British military, low-level laser therapy is non-invasive and produces no known side effects.

The low-level lasers approved by the FDA are completely safe. “Laser light is as gentle as the kiss of a butterfly,” Dr. Larry Lytle, in his book “Universal Healer, Osteoarthritis,” “but from a healing perspective, it is quite possibly more effective than drugs or surgery.”

For more information about the QLaser and to receive a free copy of Dr. Lytle’s book, “Universal Healer, Osteoarthritis,” go to www.qlasersolutions.com and enter the code 5385 in the dropdown menu.To receive a free information packet by mail, call 1-800-597-9231 and use the code 5385 when requested.

Dr. Lytle is available for interviews. To arrange an interview, please e-mail kip@rapidnet.com.

FDA Approves Low-Level Laser for Osteoarthritis

<b>FDA Approves Low-Level Laser for Osteoarthritis</b>“></td>
<p>(<a href=NewsUSA) – Osteoarthritis, a degenerative disease in which joint cartilage wears away over time, proves a common problem. According to the Centers for Disease Control and Prevention (CDC), approximately one-third of American adults suffer from chronic arthritis.

The pain of osteoarthritis not only affects Americans’ joints, but also their wallets. Thirty-three percent of American workers report that arthritis interferes with their ability to perform their job. In 2007, treating arthritis cost $128 billion — $81 billion in direct expenses, like medical costs, and another $47 billion in lost wages and other indirect costs.

Osteoarthritis typically affects older adults, but it does not affect every senior citizen. It can strike any animal with a bony skeleton, causing pain and disability.

“No one needs to describe that the pain comes and goes, prevents sleep, makes walking difficult, causes you to drop or spill things, and renders you unable to sign your name or write,” writes Dr. Larry Lytle in his book, “Universal Healer: Book I Osteoarthritis.” “In short, it is the most common form of disability.”

Osteoarthritis cannot currently be cured, but effective treatments can improve the quality of life of millions of people. To many people, it comes as exciting news that the FDA has recently approved a low-level laser treatment, the QLaser, for treating osteoarthritis in the hands.

The Q1000 is a Class I laser device that has been classified by the FDA as a non-significant risk device as related to eye injuries, yet helps the body release endorphins (natural painkillers) reduce inflammation, increase circulation, help heal damaged cell membranes and boost cells’ energy levels, resulting in less pain and more healing. Keeping a personal laser, like the QLaser, at home can help patients address their osteoarthritis without turning to costly medical treatments.

For more information about the QLaser and to receive a free copy of Dr. Lytle’s book, “Universal Healer: Book I Osteoarthritis,” go to the Web site qlasersolutions.com and enter the promotional code 5260 in the dropdown menu. To receive an information packet, call 1-800-597-9231 and use promotional code 5260. Dr. Lytle is available for interviews. To arrange an interview, please e-mail kip@rapidnet.com.